$Novo Nordisk AS(NVO.US) is expected to see revenue drop by 5%-13% in 2026.
Taking the midpoint between the recent month's high of 64 and low of 44, around 59, for a simple calculation: 59x0.95≈56, 59x0.87≈51.
So, ignoring other factors, Novo Nordisk's stock price is relatively reasonable between 51-56. Of course, this hasn't yet accounted for the impact of the interest rate cut cycle.
Therefore, I estimate that the real price of Novo Nordisk is within the 51-80 range, which is normal.
Below 50 is undervalued.
51 to 60 is normal.
61 to 70 is a slight bubble.
71 to 80 is a moderate bubble.
Above 81 is a severe bubble.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
